A detailed history of Campbell & CO Investment Adviser LLC transactions in Novavax Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 189,426 shares of NVAX stock, worth $1.81 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
189,426
Holding current value
$1.81 Million
% of portfolio
0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$5.43 - $7.74 $1.03 Million - $1.47 Million
189,426 New
189,426 $1.19 Million
Q2 2022

Aug 09, 2022

SELL
$36.28 - $75.29 $295,028 - $612,258
-8,132 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$69.73 - $142.9 $567,044 - $1.16 Million
8,132 New
8,132 $599,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $747M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.